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Department of Physiology and Biophysics, State University of New York, Buffalo, New YorkABSTRACT The temperature dependence of agonist binding and channel gating were measured for wild-type adult neuro-
muscular acetylcholine receptors activated by acetylcholine, carbamylcholine, or choline. With acetylcholine, temperature
changed the gating rate constants (Q10z 3.2) but had almost no effect on the equilibrium constant. The enthalpy change asso-
ciated with gating was agonist-dependent, but for all three ligands it was approximately equal to the corresponding free-energy
change. The equilibrium dissociation constant of the resting conformation (Kd), the slope of the rate-equilibrium free-energy rela-
tionship (F), and the acetylcholine association and dissociation rate constants were approximately temperature-independent. In
the mutant aG153S, the choline association and dissociation rate constants were temperature-dependent (Q10 z 7.4) but Kd
was not. By combining two independent mutations, we were able to compensate for the catalytic effect of temperature on the
decay time constant of a synaptic current. At mouse body temperature, the channel-opening and -closing rate constants are
~400 and 16 ms1. We hypothesize that the agonist dependence of the gating enthalpy change is associated with differences
in ligand binding, specifically to the open-channel conformation of the protein.INTRODUCTIONNicotinic acetylcholine receptors (AChRs) are ligand-gated
ion channels at vertebrate nerve-muscle synapses. These
five subunit allosteric proteins regulate the flow of cations
across muscle cell membranes by alternatively adopting
conformations that have either a low affinity for agonists
and a closed channel (resting, R) or a high affinity for
agonists and an open channel (active, R*) (1–4). Each
AChR has two ligand-binding sites in the extracellular
domain. The neurotransmitter acetylcholine (ACh) is
a potent activator of AChRs because when the protein
changes shape from resting to active, the affinity for this
ligand increases by ~6300-fold at each binding site (5,6).
Other partial agonists are weaker activators because they
experience a smaller increase in affinity.
The logarithm of an equilibrium constant is proportional
to the free-energy difference between the ground states
(here, R and R*), and the logarithm of a rate constant is
proportional to the free-energy difference between the
ground and transition states (7). Free energy is comprised
of enthalpy and entropy components. At constant pressure,
the enthalpy change between R and R* informs us about
the heat absorbed (or emitted) within the isomerization,
and is revealed experimentally as the degree to which the
equilibrium constant changes with temperature. Knowing
the amount of heat exchange that takes place within
AChR gating may help illuminate its mechanism, i.e., the
ensemble of energy and structural changes that occur
when the protein changes shape between R and R*.Submitted July 15, 2010, and accepted for publication December 16, 2010.
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0006-3495/11/02/0895/9 $2.00The temperature dependence of neuromuscular AChR
gating has been investigated previously, but not at the level
of rate and equilibrium constants. Earlier studies measured
the temperature dependence of single-channel bursts or end-
plate-current (epc) decay time constants, which reflect
a combination of binding and gating processes. In those
studies, the temperature coefficient (Q10) of this time constant
was in the range of 2–4, which translates to an activation
enthalpy of 13–24 kcal/mol (8–12). Based on the correlation
between the polarization of the lipid probe laurdan and the
single-channel burst time constant, Zanello et al. (11)
proposed that the temperature dependence of gating (as well
as conductance) is primarily influenced by the physical state
of the membrane, which in turn is influenced by temperature.
In this work, we separately quantified the effects of
temperature on agonist binding and channel gating in adult
mouse AChRs activated by ACh, carbamylcholine (CCh), or
choline (Cho). The results indicate that the different abilities
of these agonists to activate the receptor can be attributed to
different enthalpies associated with binding to the high-
affinity R* conformation.MATERIALS AND METHODS
HEK 293 cells plated on 22 mm polylysine-coated glass coverslips were
transiently transfected with a mixture of cDNAs encoding wt or mutant
mouse AChR subunits via calcium phosphate precipitation (a, b, d, and 3;
1.8 mg total DNA in a 2:1:1:1 ratio). The culture medium was changed after
16 h and electrophysiological recordings commenced 18–24 h later. Muta-
tions were made using the QuikChange Mutagenesis Kit (Stratagene, La
Jolla, CA) and confirmed by dideoxy sequencing.
Single-channel recordings were from cell-attached patches. Rate
constants at a given temperature were estimated for each construct from
several patches obtained on different days and from different culture dishes.
The pipette potential wasþ80mV (except where noted), which correspondsdoi: 10.1016/j.bpj.2010.12.3727
896 Gupta and Auerbachto a membrane potential of ~100 mV. Pipettes were pulled from borosili-
cate capillaries and coated with Sylgard (Dow Corning, Midland, MI). The
bath and pipette solutions were Dulbecco’s phosphate-buffered saline
containing (mM) 137 NaCl, 0.9 CaCl2, 2.7 KCl, 1.5 KH2PO4, 0.5 MgCl2,
and 8.1Na2HPO4 (pH7.4), except for the current-voltage relationship exper-
iments, in which both the bath and pipette solutions contained (mM)
142 KCl, 5.4 NaCl, 1.8 CaCl2, 1.7 MgCl2, and 10 HEPES/KOH (pH 7.4).
The temperature of the bath was maintained at 50.2C of the desired
value and was allowed to stabilize before each recording. This took
~3 min for every 5C change in temperature. The temperature was
controlled by a Peltier device mounted on a copper plate under the perfu-
sion chamber (Brook Industries, Lake Villa, IL). The temperature of the
patch during the experiment was monitored with a miniature thermocouple
placed ~1 mm from the pipette tip. Single-channel currents were first re-
corded at 20C and then the temperature was either increased or decreased
in 5C increments. Recordings were made for ~3 min at each temperature.
Each point in the Arrhenius and van ’t Hoff plots is the average obtained
from at least three different patches.
Single-channel currents were low-pass filtered at 20 kHz and digitized at
a sampling frequency of 50 kHz. Agonists were added only to the pipette
solution. Kinetic analyses were carried out with the use of QUB software
(http://www.qub.buffalo.edu). At high agonist concentrations, channel
openings occurred in clusters that represent binding and gating activity of
individual AChRs. Usually, we selected the clusters by eye and idealized
the currents into noise-free intervals after digitally low-pass filtering the
currents at 12 kHz and using the segmental k-means algorithm (13), or after
low-pass filtering the currents at 5 kHz and using half-amplitude detection.
We estimated the rate constants from the idealized interval durations
by using a maximum log-likelihood algorithm (14) and a two-state,
C(losed)4O(pen) model after imposing a dead-time correction (applied
to both open and shut intervals) of 25 or 35 ms (15).
Amajor problem in the analysis of AChRs is that binding and gating reac-
tions together often determine the apparent kinetic parameters. Our primary
objective was to measure the temperature dependencies for each of these
processes separately. The single-site equilibrium dissociation constant for
binding to the R conformation (Kd) is the ratio of the agonist dissociation
(k) and association (kþ) rate constant (Kd¼ k/kþ). The diliganded gating
equilibriumconstant (E2) is the ratio of the forward (channel-opening, f2) and
backward (channel-closing, b2) rate constant (E2 ¼ f2/b2). We usually were
unable to obtain estimates of these rate and equilibrium constants directly by
using wt AChRs, so instead we obtained estimates of effective opening/
closing rates that depended on both binding and gating.
We define the inverse, principle shut interval lifetimewithin clusters to be
the effective opening rate (f*) and the inverse, principle open interval
lifetime to be the effective closing rate (b*). The effective activation equi-
librium constant is f*/b*, and the open probability of clusters (Po) is f*/
(f* þ b*). The relationship between f* and f2 depends on the agonist
concentration ([A]) and Kd, and f* < f2 except when both binding sites
are fully occupied by the agonist ([A] >> Kd). The relationship between
b* and b2 depends on the ratio f2/k2, where k2 is the rate constant for
agonist dissociation from either of the two binding sites. Ignoring desensi-
tization and dissociation of the agonist from R*:
bzb2=ð1 þ f2=k-2Þ; (1)
when f2 << k-2, b* z b2. The values reported in the tables are f* and b*
(except where noted).
Another problem with rate constant estimation is open-channel block by
the agonist. We estimated the block equilibrium dissociation constant (KB)
from the reduction in the single-channel current amplitude with increasing
agonist concentration:
KB ¼ ½AiB=ði0  iBÞ; (2)
where i0 is the single-channel current amplitude in the absence of block
(measured at a low agonist concentration), and iB is the observed single-
channel current amplitude measured at a high agonist concentration whereBiophysical Journal 100(4) 895–903block is apparent. Equation 2 is an approximation that assumes that the
dissociation rate constant of the blocker from the R* conformation is rela-
tively small compared with that from R (16,17).
The apparent open lifetime is also influenced by block:
bzb2ð1 þ ½A=KBÞ:
If KB is not temperature-dependent, the temperature dependence of b* is
not affected by channel block.
Kd was estimated for two mutant AChRs: aY127E and aG153S. aY127E
was activated by ACh and aG153S was activated by Cho. We fit the interval
durations within clusters at different agonist concentrations together by using
a linear kinetic scheme (R4RA4RA24R*A2), where A is the agonist. We
assumed that the twobinding stepswere equal and independent (5,18), and that
the association rate constant scaled linearly with the agonist concentration.
The temperature coefficient Q10 is defined as Q10¼ (P2/P1)10/[T2-T1], where
P1 and P2 are the parameter values obtained at temperatures T1 and T2. The
activation enthalpy was estimated by using the Arrhenius equation:
lnðkrateÞ ¼ lnðAÞ  Ea=RT; (3)
where krate is an experimentally determined rate constant, A* is the
prefactor, Ea is the activation enthalpy (kcal/mol), and R is the gas constant
(1.987 cal/K/mol) at temperature T (K). Ea is an approximation of the acti-
vation enthalpy of the transition state relative to a ground state, according to
transition-state theory. Ea
f pertains to the forward, opening rate constant
(from the R ground state) and Ea
b pertains to the backward, closing rate
constant (from the R* ground state). Because the Arrhenius plots for all
the constructs were approximately linear in this study, we assumed that
the heat capacity was constant with temperature. In our temperature range
(5–35C), Eaz 17ln(Q10), in kcal/mol.
We quantified the equilibrium enthalpy (DH) and entropy (DS) changes
associated with the transition between R and R* by using the van ’t Hoff
equation:
ln

Keq
¼ -DH=RT þ DS=R; (4)
where Keq is an equilibrium constant. Each point in the Arrhenius and van ’t
Hoff plots is the average obtained from at least three different patches. The
Gibbs free-energy change (DG) at a given temperature was calculated from
the van ’t Hoff plots as:
DG ¼ DH TDS
V was estimated as the linear slope of a rate equilibrium relationship that is
a log-log plot of the f2 versus E2 for a family of perturbations of a single
position in the protein (19). Points in the plot represent the mean of at least
three patches for each construct.
RESULTS
Acetylcholine
Fig. 1 shows the temperature dependence of gating in adult
wt mouse AChRs activated by the neurotransmitter ACh. At
100 mM ACh, single-channel openings occurred in clusters
that reflect diliganded R4R* gating of individual AChRs.
The silent periods between clusters are epochs when all
AChRs in the patch are desensitized. Cluster duration
increased with decreasing temperature, indicating that entry
into states associated with desensitization became slower at
lower temperatures (Fig. 1 A).
At 23C, Kd
AChz 140 mM (5); therefore, at 100 mMACh
([A] < Kd), the durations of intervals within clusters reflect
both binding and gating processes. Fig. 1 B shows example
clusters at 100 and 30 mM ACh at different temperatures.
FIGURE 1 Temperature dependence of wt
AChRs activated by ACh. (A) Low time-resolution
traces showing clusters of openings at different
temperatures (open is down; low-pass filtered at
2 kHz). At 100 mM ACh, activity within a cluster
reflects a combination of binding and gating
processes. (B) Example single-channel clusters.
(C) The cluster open probability (Po) is approxi-
mately constant with temperature at both 30 and
100 mM ACh. (D) The effective closing rate at
2 mM ACh increases with increasing temperature
(activation enthalpy, Ea¼þ19 kcal/mol; Q10 z
3.1). (E) Left and center: Arrhenius plots for the
effective opening (f*) and closing rate constants
(average Ea¼þ20 kcal/mol; Table S1). Right:
van ’t Hoff plots for the effective-gating equilib-
rium constant with corresponding DH values.
TABLE 1 van ’t Hoff analysis of wt AChRs
Agonist DH (kcal/mol) TDS (cal/mol) DG (25C) (kcal/mol)
30 mM ACh 0.8 (0.5) 0.95(0.3) 0.15
100 mM ACh 0.6 (0.3) 1.8 (0.3) 1.2
500 mM CCh 1.5 (0.3) 1.9 (0.4) 0.4
5000 mM CCh 1.8 (0.6) 2.9 (0.6) 1.1
1000 mM Cho 4.2 (0.3) 3.6 (0.3) 0.6
DH, enthalpy change (R4R*); TDS, entropy change at 25C; DG, free-
energy change (¼ DH-TDS) at 25C. Standard errors (in parentheses) are
from the least-square linear fit obtained by using Eq. 4. Agonists: ACh,
acetylcholine; CCh, carbamylcholine; Cho, choline.
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concentration, but at both concentrations it was approxi-
mately constant with temperature. The Arrhenius (see Table
S1 in the Supporting Material) and van ’t Hoff (Table 1)
analyses of the apparent activation rate and equilibrium
constants are shown in Fig. 1 E. At both concentrations,
DH for the effective activation equilibrium constant with
ACh as the agonist was ~þ0.7 kcal/mol.
At 2 mM, ACh channel openings occur as bursts with an
effective closing rate (b*) that is a function of both the dili-
ganded channel-closing rate constant (b2) and the agonist
dissociation rate constant (Eq. 1). The Arrhenius plot of
ln (b*) versus 1/T was well described by a straight line,
with an activation enthalpy of þ19.0 kcal/mol (Fig. 1 D).
The above experiments show that Po is not highly tempera-
ture-dependent in wt AChRs activated by ACh. Because both
binding and gating contribute to Po, it was possible that the
opposite temperature sensitivities of these two distinct
processes could cancel each other. Our first goal was tomeasure separately the temperature dependencies of ACh
binding and gating. We could not achieve this objective using
wtAChRs activated byACh because the channel-opening rate
constantwas too fast.Wecould, however, separate binding and
gating parameters in the mutant aY127E activated by ACh
(Fig. 2). Mutations of this residue do not influence Kd
ACh
(20), so at 500mMACh the transmitter binding sites are almostBiophysical Journal 100(4) 895–903
FIGURE 2 Temperature dependence of aY127E
AChRs activated by ACh. (A) Clusters of openings
at different temperatures and ACh concentrations,
with the corresponding shut interval-duration
histograms. Solid lines in histograms were calcu-
lated from the global fit using a model with two
equal and independent binding steps followed by
a gating step. (B) Equilibrium dissociation constant
for ACh from the low-affinity conformation
(Kd
Ach) is approximately constant with tempera-
ture (Table S3). (C) Left: Single-channel current
amplitude, Q10z1.3. Right: Equilibrium dissocia-
tion constant for channel block by the agonist (KB)
is not temperature-dependent.
898 Gupta and Auerbachfully saturated (Eq. 1). Because this mutation also substan-
tially slows the channel-opening rate constant, the apparent
activation parameters of intervals within clusters at this
concentration reflect mainly gating. By examining currents
activated by several different ACh concentrations, we could
also estimate the temperature dependence of Kd
ACh in this
mutant.
Fig. 2 A shows clusters of currents from aY127E AChRs
activated by different ACh concentrations and at different
temperatures, alongwith the corresponding shut interval dura-
tion histograms. At the highest ACh concentration, the open
and shut intervals associated with gating are clearly resolved.
Fig. 2 B (Table S3) shows that in aY127E, Kd
ACh was approx-
imately the same as in wt AChRs and was constant with
temperature. Further, the ACh association and dissociation
rate constants (which were also about the same as in the wt)
did not change significantly with temperature. These results
demonstrate that ACh binding to the R conformation is not
temperature-dependent in aY127E. Fig. 2 C shows the
temperature dependenciesof the single-channel current ampli-
tude (i0) and the equilibrium dissociation constant for channelBiophysical Journal 100(4) 895–903block byACh (KB). Between 20
C and 30C, theQ10 of i0 was
~1.3 and KB was essentially constant.
If we assume that in wt AChRs Kd is independent of
temperature (as it is inaY127E), then the temperature depen-
dence of the effective gating rate constants at 30 and 100 mM
ACh (Fig. 1 E, right) can be used to approximate the temper-
ature dependence of E2
ACh. Hence, we estimate DH for
gating in wt AChRs activated by ACh is þ0.7 kcal/mol
(Q10z 1.04). This indicates that when ACh is the agonist,
there is almost no heat absorbed by wt AChRs during the
R-to-R* conformational change. However, temperature has
a large catalytic effect on gating and substantially influences
both the forward and backward isomerization rate constants.
This indicates that there is a large enthalpic component in the
free energy of the gating transition state.Choline
Fig. 3, A–C, show the results for wt AChRs activated by the
partial agonist Cho. Cho is a breakdown product of ACh that
is present physiologically at cholinergic synapses and has
FIGURE 3 Temperature dependence of AChRs
activated by Cho. (A–C) wt. (D–F) aG153S. (A)
Example wt clusters activated by 10 mM Cho at
different temperatures. (B) Top left and center: Ar-
rhenius plots for opening (f*) and closing rate (b*)
constants at 10 mM Cho (Table S1). Bottom left:
van ’t Hoff plot for the effective equilibrium
constant (f*/b*) (DH ¼ þ4.2 kcal/mol). Bottom
right: Arrhenius plot for the closing rate constant
at 200 mM Cho. (C) Top: Single-channel current-
voltage (I/V) relationships at different tempera-
tures (200 mM Cho). The zero-current potential
changes little with temperature (range: 6.9
to þ3.4 mV). Bottom: The single-channel conduc-
tance has a Q10 of 1.3 (20–30
C). (D) Clusters and
corresponding shut interval-duration histograms
for aG153S AChRs at different Cho concentrations
and temperatures. Solid lines in histograms were
calculated from the global fit using a model with
two equal and independent binding steps followed
by a gating step (Table S3). (E) Arrhenius plots for
the dissociation (k) and association (kþ) rate
constants (average. Q10 ~ 7.4). (F) The equilibrium
dissociation Kd
Cho shows little temperature depen-
dence.
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Choz 4 mM). Cho is a low-
efficacy agonist because this ligand experiences only a small
increase in affinity when the protein changes shape from
R to R*. The gating free-energy difference between these
two agonists (calculated from the natural logarithm of the
gating equilibrium constant ratio, E2
ACh/E2
Cho) is
DDGo ¼ þ3.9 kcal/mol. Because measurements with these
agonists were made using the same background AChR (wt),
this free-energy difference can be attributed exclusively to
the R/R* equilibrium dissociation constant ratio, which is
6300 for ACh but only 270 for Cho (5,6).
For Cho, the channel-opening rate constant is small and at
200 mM (where there is little channel block), b2z b*. In wt
AChRs activated by Cho, this closing rate constant became
smaller at lower temperatures with an apparent activation
enthalpy (Ea
b) of þ20.7 kcal/mol (Fig. 3 B, lower right),
which is slightly larger than the temperature dependence of
b* for ACh-activated wt AChRs. Example clusters of wt
AChRs activated by 10 mM Cho at different temperatures
are shown in Fig. 3 A. At this concentration, both binding
and gating contribute to the activation kinetics (Table S2),but we were unable to use higher Cho concentrations because
of channel-block by agonist molecules. The temperature
dependence of the effective rate and equilibrium constants
at 10 mM Cho are shown in Fig. 3 B (Table 1 and Table
S1). DH for this equilibrium constant was þ4.2 kcal/mol.
To separately estimate the effects of temperature on Cho
binding and gating, we studied the mutant aG153S. This
residue is in the vicinity of the transmitter-binding site
and causes a human slow-channel myasthenic syndrome
(21). The Ser mutation increases E2 by an approximately
parallel change in the unliganded gating equilibrium
constant but has only a small effect on the R/R* equilibrium
dissociation constant ratio (22). The main advantage of
using this mutation is that it increases the affinity of the R
conformation for Cho.
Fig. 3 D shows example aG153S clusters and shut interval
duration histograms at different Cho concentrations and
temperatures. Table S3 shows the binding rate and equilibrium
constant estimates. At 25C, Kd
Cho in aG153S was ~265 mM,
which is ~15 times lower than the wt. Fig. 3 B shows the cor-
responding Arrhenius plots for binding. In sharp contrast toBiophysical Journal 100(4) 895–903
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constants both decreased markedly with a decrease in temper-
ature (activation enthalpies of 325 3 and 345 4 kcal/mol;
Q10z 7.4). Fig. 3 C (Table S3) shows that both of these rate
constants changed to about the same extent with temperature,
so that in aG153SKd
Chowas approximately constant between
25C and 5C. Thus, temperature has a mainly catalytic effect
on Cho binding to aG153S AChRs.
If we assume that Kd
Cho is also approximately tempera-
ture-independent in wt AChRs, we can use the van ’t Hoff
slope obtained at 10 mM Cho as an estimate of the enthalpy
change of gating in wt AChRs (Table 1). This value was
larger than that for ACh-activated wt AChRs. Relative to
ACh, Cho-activated wt AChRs exchange more heat with
the bath in the gating conformational change
(DDHCho ¼ þ3.5 kcal/mol).
Fig. 3 C shows the temperature dependence of the single-
channel current/voltage relationship for wt AChRs activated
by Cho. The conductance had a Q10 of 1.3 (between 20
C
and 30C) and the zero-current potential did not change
significantly with temperature.
Carbamylcholine
We also studied the partial agonist, CCh. At 25C, E2 for
CCh is 5.3 (DDGo ¼ þ0.9 kcal/mol, compared with ACh)
(6). The R/R* equilibrium dissociation constant ratio for
CCh is ~2870, which is larger than that for Cho but less
than that for ACh (6).
Fig. 4 A shows example clusters of wt AChRs activated by
5 mMCCh at different temperatures. In wt AChRs, Kd
CChz
1mM, so the intracluster intervals at 5 mM reflect mainly the
gating conformational change. Fig. 4 B shows the tempera-
ture dependence of the rate and equilibrium constants at
5 mM and 500 mM CCh (where both binding and gating
contribute to the estimates). The activation and equilibriumFIGURE 4 Temperature dependence of wt AChRs activated by CCh. (A) Exam
center: Arrhenius plots for the effective gating rate constants. (Table S1) Righ
DH ¼ þ1.7 kcal/mol).
Biophysical Journal 100(4) 895–903enthalpy estimates were approximately the same at both
concentrations (Table 1 and Table S1). This result suggests
that in wt AChRs, Kd
CCh is not temperature-dependent. We
estimate that compared with ACh-activated wt AChRs,
DDHCCh ¼ þ1.0 kcal/mol for gating.F-Value analysis
Agonists and mutations change E2 by changing f2, b2, or
both. The slope of the rate equilibrium plot (F) is a measure
of the extent to which a perturbation changes f2 versus b2.
F-Values are fractions between 0 and 1, with higher
numbers indicating a greater effect on f2 compared with
b2. Fig. 5 A shows the rate equilibrium plot for ACh, CCh,
and Cho (wt AChRs) at two different temperatures. Fig. 5
B shows that at all tested temperatures, F ~ 1.Temperature dependence of the epc
The approximate time constant of the epc decay is the same
as the mean lifetime of bursts:
tepczð1 þ f2=k2Þ

b2; (5)
where k2 is the sum of the rate constants for agonist disso-
ciation from the two resting AChR transmitter-binding sites.
tepc approaches 1/b2 only when the ratio f2/k-2 is small. This
is not the case at the neuromuscular synapse because the
number of openings per burst (¼1þf2/b2) is >1. The
temperature dependence of tepc is therefore a function of
the temperature dependencies of all three rate constants in
Eq. 5.
We were able to estimate the temperature dependence of
tepc in two ways. One estimate is simply the temperature
dependence of b* in wt AChRs activated by 2 mM ACh
(19.0 5 0.9 kcal/mol; Table S1). We made a second esti-
mate assuming that in wt AChRs, the temperatureple clusters activated by 5 mM CCh at different temperatures. (B) Left and
t: van ’t Hoff plot for the effective gating equilibrium constant (average
FIGURE 5 Rate-equilibrium analyses. (A) Log-log plots of the forward,
opening rate constant versus the gating equilibrium constant for different
agonists at two different temperatures. The slope (5SE) of the least-
squares linear fit (F) is shown in each panel. (B) F (ACh, CCh, and Cho)
is approximately independent of temperature.
Temperature and AChR Agonists 901dependencies of f2 and b2 are the same (Ea
f,bz 20 kcal/mol)
and that k2 is temperature-independent. Accordingly, we
calculated tepc at different temperatures and fitted the values
by the Arrhenius equation. The estimated activation
enthalpy was 18.35 1.2 kcal/mol. The agreement between
these two values supports the assumptions.
We then used this activation enthalpy to compute the epc
decay at mouse body temperature (39C). At 23C
(~100 mV), the adult mouse ACh gating rate constants
are f2 ¼ 66,000 s1 and b2 ¼ 2600 s1 (6), and tepc z
1.0 ms. Using an activation enthalpy of 19 kcal/mol for
both the forward and backward rate constants (and the rela-
tionship QDT ¼ Q10DT/10), we estimate that at 39C the rate
constants are ~6 times faster than at 23C. We calculate
that in the mouse, f2z 396,000 s
1, b2z 15,600 s
1, and
tepc z 0.7 ms, and that the average number of openings
per burst is ~11. Despite the high Q10 for the gating rate
constants, tepc decreases onlymodestly at high temperatures.
This is because the number of openings per burst increases
with temperature (f2 >> k-2), so that tepc z E2/k2. With
the natural transmitter and under this condition, E2, k2,
and tepc change little with temperature.
Finally, we carried out an exercise in protein engineering.
We sought to mutate the wt AChR to compensate for the
effect of temperature on the gating rate constants, and
hence, tepc. Specifically, our goal was to design and express
AChRs that would give rise to a tepc at 10
C that would be
the same as for wt AChRs at 23C, but without altering the
equilibrium dose-response properties, which depend on both
Kd and E2 (we did not try to compensate for channel conduc-tance or the amplitude of the epc). In wt AChRs activated by
ACh, a 13C reduction in temperature would be expected to
slow the gating rate constants by ~4.3-fold and tepc by ~2.3-
fold (Eq. 5).
Almost all point mutations in the AChR that have been
studied so far alter both the gating rate and equilibrium
constants; therefore, to achieve our goal, we had to combine
two separate mutations. One mutation was aD97Q (in loop
A of the extracellular domain), which was previously shown
to increase E2 mainly by increasing f2 (a gain-of-function,
high-F mutation) (23). The other mutation was 3I257A
(in the pore-lining M2 helix), which was shown to decrease
E2 approximately to the same extent, but by increasing b2
(a loss-of-function, low-F mutation) (24). If these two
mutations are energetically independent, we might expect
the E2 of the double-mutant construct to be the same as
for the wt, but with faster opening and closing rate
constants. In this case, the two mutations in combination
would compensate for the catalytic effect of temperature
but have little effect on Kd or E2.
Table S4 shows the experimental results. aD97Q alone
increased E2, mostly by virtue of an ~50-fold increase in
f2. 3I257A alone decreased E2 by about the same extent,
partly because it increased b2 by ~5-fold. Fig. 6 shows
example single-channel currents from AChRs having either
or both of these mutations. The single-channel analysis
shows that the aD97Qþ3I257A double mutant approxi-
mately changed the gating parameters by the expected
amounts, assuming energy independence. Further, at 10C
the double-mutant construct exhibited gating rate constants
that were similar to those for wt AChRs at 23C (Table S4).
We used these rate constants to simulate synaptic currents at
each temperature, keeping k2 constant at 40 ms
1. Fig. 6 B
shows that this mutant pair can approximately compensate
for the catalytic effect of temperature on the synaptic current
decay time constant.DISCUSSION
With the natural transmitter, the wt AChR gating equilib-
rium constant is almost constant with temperature
(5–35C). We estimate that in the R-to-R* isomerization,
only ~þ0.7 kcal/mol (2.9 kJ/mol) of heat is absorbed from
the bath. The relative temperature insensitivity of the gating
equilibrium constant is remarkable because many residues
in this >2000 residue (~300 kD), five-subunit membrane
protein change free energy in the gating isomerization.
A priori, we expected a larger net heat exchange in such
a large, widespread, and complex reaction. In wt AChRs,
the equilibrium dissociation constants for agonist binding
to the transmitter-binding site or to the channel-blocking
site in the pore hardly changed with temperature; however,
these results are easier to rationalize because the conforma-
tional changes associated with these processes are likely to
be less extensive. We cannot think of a natural selectionBiophysical Journal 100(4) 895–903
FIGURE 6 Engineering the synaptic response. The AChR was mutated
to compensate for the catalytic effect of temperature on gating and the
time course of the synaptic current decay. (A) Example clusters from wt,
aD97Q, 3I257A, and the double mutant aD97Qþ3I257A. aD97Q, and
3I257A had approximately equal and opposite effects on the gating equilib-
rium constant (see Fig. 4 A for an example cluster, 5 mM CCh and 20C).
aD97Q increases the opening rate constant and 3I257A increases the
closing rate constant (Table S4). The cluster Po (the gating equilibrium
constantz 0.05) was approximately the same in the wt at 23C and double
mutant at 10C. (B) Simulated synaptic current decay for the wt and double
mutant AChRs at different temperatures. The decay time constant for the wt
at 23C (tepc z 1.0 ms) is similar to that for the double mutant at 10C
(~1.1 ms) but faster than that for the wt at 10C (~2.3 ms). When combined,
these two mutations compensate for the catalytic effect of temperature.
902 Gupta and Auerbachpressure that would tend to eliminate temperature depen-
dence from the gating of mouse muscle AChRs.
In wt AChRs, the activation enthalpy for gating is large
(~20 kcal/mol; Q10 ~ 3.2) for both the opening and closing
rate constants. Activation enthalpies of similar magnitudes
have been reported for gating of other ion channels
(25–28) and for protein folding (29–32). The AChR
channel-opening rate constant is fast (at 23C, ~66 ms1)
and mutations can make it even faster (33). Although the
free energy of the transition state is not known with
certainty, two separate lines of evidence suggest that it
may be ~4 kcal/mol (33,34). Apparently, the large barrier
enthalpy is offset by a correspondingly large entropy, which
allows the reaction to proceed apace at body temperature.
We examined the temperature dependencies of binding
and gating in wt AChRs for three agonists: ACh, CCh,
and Cho. For all three, the equilibrium dissociation constant
of the resting conformation was approximately independent
of temperature. The association and dissociation rate
constants were also temperature-independent for ACh and
aY127E AChRs, but those for Cho and aG153S varied
sharply with temperature (Q10 z 7.4). We speculate thatBiophysical Journal 100(4) 895–903this difference can be attributed to the aG153S mutation
rather than to the agonist. Perhaps a loss of backbone flexi-
bility here causes the extra enthalpy at the transition state of
the binding process (22).
At 25C, the gating DGo (calculated from the natural
logarithm of the gating equilibrium constant, E2) is different
for AChRs activated by ACh, CCh, or Cho (1.9, 1.0,
and þ1.8 kcal/mol, respectively). Compared with ACh,
the relative gating free-energy change with two CCh or
Cho molecules bound is DDGo¼ þ0.9 or þ3.7 kcal/mol.
From our measurements, we conclude that the enthalpy
components of these free-energy differences are also
agonist-dependent. In comparison with ACh, we estimate
that the relative gating enthalpy change with two CCh or
Cho molecules bound is DDH ¼ þ1.0 or þ3.5 kcal/mol.
The net free energy and enthalpy values are approximately
equal. The differences in the free energy between the three
agonists can be attributed entirely to differences in enthalpy,
and hence the entropy change associated with gating is
approximately the same for these ligands.
To a first approximation, enthalpy changes can be associ-
ated with bonds, and entropy changes can be associated with
water and structural dynamics. These results suggest that the
change in bonding, R-to-R*, is different for different
agonists. The physical event that determines agonist differ-
ences in E2 is the R/R* equilibrium dissociation constant
ratio (Kd/Jd). We observed that Kd is temperature-indepen-
dent for all three agonists, so we can specifically associate
the gating enthalpy differences between agonists with
differences in ligand-protein bonds in the high-affinity,
open-channel complex (Jd).
Without high-resolution structures of AChRs in R and R*
occupied by ACh, CCh, and Cho, it is difficult to pinpoint
the exact nature of the bond differences between these
agonist molecules. Kd is influenced in part by cation-p inter-
actions between the quaternary amine group of ACh and
aW149 (35), and it is possible that this interaction increases
to different extents with ACh, CCh, and Cho when the
protein adopts R*. It is also possible that the differences
in chemical bonding in R* between the three agonists arise
from interactions of the ligand with other atoms in the
protein or with water, or even from bond strain within the
ligand itself. Probing the relative free energy and enthalpy
changes for more agonists and AChRs with mutations of
binding-site residues may shed light on this matter.
We sometimes made multiple perturbations and found
that their effects were in all cases energetically independent.
aY127E did not change Kd (or the binding rate constants)
for ACh, which indicates that this side-chain substitution
does not interact with the agonist molecule or with residues
that determine resting affinity. The channel conductance
was the same with all agonists and mutations, indicating
that regions of the pore that influence ion permeation rates
were also not perturbed. The effects of aD97A and
3I257A on the gating equilibrium constant were
Temperature and AChR Agonists 903independent. It is this independence of free-energy conse-
quences on both the transition and ground states that
allowed us to engineer AChRs so that the catalytic effect
of temperature could be eliminated.
Our results indicate that at adult mouse neuromuscular
synapses, each AChR opens an average of ~11 times in rapid
succession before a transmitter molecule dissociates to
terminate the burst. At 39C, the gaps arising from sojourns
in the diliganded-R state are extremely brief (~2 ms) and
would not be apparent in electrophysiological recordings.
Indeed, gaps arising from channel block by the agonist
would probably be longer in duration. The opening rate
constant at mouse body temperature approaches the esti-
mated maximum for the forward isomerization rate constant
(33). It appears that the process of natural selection has
generated an allosteric protein that operates near its phys-
ical-chemical speed limit.
Elsewhere, we consider the effects ofmutations (including
aY127E and aG153S) on the enthalpy and entropy changes
in the AChR gating conformational change (36).
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